You are here

  • Home
  • Archive
  • Volume 29, Issue Suppl 4
  • EP822 Simvastatin enhances the anti-tumoral effect of metronomic cyclophosphamide against cancer-initiating cells (CICs) by reducing ALDH1A1 expression both in vitro and in vivo: an effective combination to overcome resistance and limit the spread of the…

Article metrics

Article menu
Download PDFPDF
ePoster
EP822 Simvastatin enhances the anti-tumoral effect of metronomic cyclophosphamide against cancer-initiating cells (CICs) by reducing ALDH1A1 expression both in vitro and in vivo: an effective combination to overcome resistance and limit the spread of the recurrent disease in high-grade serous ovarian cancer (HGSOC)

 

Online download statistics by month:

Online download statistics by month: November 2019 to April 2024

AbstractFullPdf
Nov 20191401
Dec 2019202
Jan 2020200
Feb 20201400
Apr 20201401
May 20201202
Jun 20201501
Jul 20202900
Aug 20201200
Sep 20203200
Oct 20205000
Nov 20207800
Dec 20202000
Jan 20212500
Feb 20212000
Mar 2021800
Apr 20211200
May 20211001
Oct 2021400
Nov 2021800
Dec 20211000
Jan 2022800
Feb 20222801
Mar 20221400
Apr 2022200
May 2022800
Jun 2022800
Jul 2022600
Aug 20221000
Sep 2022400
Oct 2022800
Nov 20221400
Dec 20221000
Jan 2023600
Feb 2023800
Mar 20231000
Apr 2023400
May 20231000
Jun 2023200
Jul 20231400
Aug 2023800
Sep 2023400
Oct 2023200
Nov 20235100
Dec 20231600
Jan 2024200
Feb 20241200
Mar 20241400
Apr 20241000
Total68409